C-KIT MUTATION DETECTION PCR (OS118) - Delhi
OUTSOURCE
|
Radiology
Also Known As:
c-Kit mutations are associated with shorter survival and higher relapse risk following standard AML therapy in AML Patients. It also confirms diagnosis of Systemic Mastocytosis where patients without the D816V pathogenic variation are sensitive to the tyrosine kinase inhibitor Imatinib mesylate (Imatinib).
-
Home Collection: Not Available
-
Reports Available: 1 Day
TAT Policy
The Turnaround Time (TAT) for a test depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
Please note that in uncommon circumstances, TAT may be delayed due to the complexity of the test or reasons beyond our control. You will be informed about the estimated TAT at the time of registration or after completion of the test.